World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
98
Citations
59915
World Ranking
8734
National Ranking
265

Overview

Raoul Herbrecht is affiliated with the University of Strasbourg in France and has contributed extensively to research in medicine, with a particular focus on infectious diseases, epidemiology, oncology, hematology, and cell biology. Their work encompasses over 100 publications, prominently addressing fungal infections and antifungal resistance.

Their research spans several main topics including:

  • Antifungal resistance and susceptibility
  • Fungal infections and studies
  • Neutropenia and cancer infections
  • Plant pathogens and fungal diseases
  • Infectious diseases and mycology
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Mycotoxins in agriculture and food

Raoul Herbrecht has frequently published in the following venues:

  • Leukemia
  • Medical Mycology
  • British Journal of Haematology
  • Emerging Infectious Diseases
  • Infectious Diseases Now

Notable recent papers include:

  • COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA), 2021, Journal of Hematology & Oncology
  • Evaluation of Serum Mucorales Polymerase Chain Reaction (PCR) for the Diagnosis of Mucormycoses: The MODIMUCOR Prospective Trial, 2022, Clinical Infectious Diseases
  • Invasive Pulmonary Aspergillosis, 2020, Seminars in Respiratory and Critical Care Medicine
  • Antifungal Therapy: New and Evolving Therapies, 2020, Seminars in Respiratory and Critical Care Medicine
  • Voriconazole plus terbinafine combination antifungal therapy for invasive Lomentospora prolificans infections: analysis of 41 patients from the FungiScope® registry 2008-2019, 2020, Clinical Microbiology and Infection

Frequent collaborators include:

  • Fanny Lanternier
  • François Danion
  • Valérie Letscher-Bru
  • Marie-Pierre Ledoux
  • Livio Pagano

Best Publications

  • CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma

    Bertrand Coiffier;Eric Lepage;Josette Briere;Raoul Herbrecht

  • Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

    Ben De Pauw;Thomas J. Walsh;J. Peter Donnelly;David A. Stevens

  • Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis

    Raoul Herbrecht;David W. Denning;David W. Denning;Thomas F. Patterson;John E. Bennett

  • Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America

    Thomas J. Walsh;Elias J. Anaissie;David W. Denning;Raoul Herbrecht

  • Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the infectious diseases society of America

    Thomas F. Patterson;George Richard Thompson;David W. Denning;Jay A. Fishman

  • Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline

    A. J. Ullmann;J. M. Aguado;S. Arikan-Akdagli;D. W. Denning

  • ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients.

    O.A. Cornely;M. Bassetti;T. Calandra;J. Garbino

  • Efficacy and Safety of Voriconazole in the Treatment of Acute Invasive Aspergillosis

    David W. Denning;Patricia Ribaud;Noel Milpied;Denis Caillot

  • Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial

    Johan A. Maertens;Issam I. Raad;Kieren A. Marr;Thomas F. Patterson

  • Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: An externally controlled trial

    Thomas J. Walsh;Issam Raad;Thomas F. Patterson;Pranatharthi Chandrasekar

  • Liposomal Amphotericin B as Initial Therapy for Invasive Mold Infection: A Randomized Trial Comparing a High–Loading Dose Regimen with Standard Dosing (AmBiLoad Trial)

    Oliver A. Cornely;Johan Maertens;Mark Bresnik;Ramin Ebrahimi

  • Imaging findings in acute invasive pulmonary aspergillosis: Clinical significance of the halo sign

    Reginald E. Greene;Haran T. Schlamm;Jörg W. Oestmann;Paul Stark

  • Phase III Study to Evaluate Temsirolimus Compared With Investigator's Choice Therapy for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma

    Georg Hess;Raoul Herbrecht;Jorge Romaguera;Gregor Verhoef

  • Isavuconazole Treatment for Mucormycosis: A Single-Arm Open-Label Trial and Case-Control Analysis

    Francisco M. Marty;Luis Ostrosky-Zeichner;Oliver A. Cornely;Kathleen M. Mullane

  • ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients

    Frederic Tissot;Samir G. Agrawal;Livio Pagano;Georgios Petrikkos

  • Posaconazole as salvage therapy for zygomycosis

    R. N. Greenberg;R. N. Greenberg;K. Mullane;J. A H Van Burik;I. Raad

  • Phase III Randomized Study of Bendamustine Compared With Chlorambucil in Previously Untreated Patients With Chronic Lymphocytic Leukemia

    Wolfgang U. Knauf;Toshko Lissichkov;Ali Aldaoud;Anna Liberati

  • European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3—2009 Update

    J Maertens;O Marchetti;R Herbrecht;O A Cornely

  • Defining Responses to Therapy and Study Outcomes in Clinical Trials of Invasive Fungal Diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria

    Brahm H. Segal;Raoul Herbrecht;David A. Stevens;David A. Stevens;Luis Ostrosky-Zeichner

  • A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients.

    H. G. Prentice;I. M. Hann;R Herbrecht;M Aoun

Frequent Co-Authors

Oliver A. Cornely
Oliver A. Cornely University of Cologne
Olivier Lortholary
Olivier Lortholary Université Paris Cité
Claudio Viscoli
Claudio Viscoli University of Genoa
David W. Denning
David W. Denning University of Manchester
Catherine Cordonnier
Catherine Cordonnier Paris-Est Créteil University
John R. Wingard
John R. Wingard University of Florida
Christian Gisselbrecht
Christian Gisselbrecht Université Paris Cité
Bertrand Coiffier
Bertrand Coiffier Centre Hospitalier Lyon Sud
Paul E. Verweij
Paul E. Verweij Radboud University
Denis Caillot
Denis Caillot Grenoble Alpes University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're interested in Medicine but want flexible education options, there are several online degrees that can help you advance your career. For those aiming for healthcare leadership or administration, consider cahme accredited online mha programs. These programs ensure high-quality, accredited training for future healthcare managers.

Registered nurses who want to further their qualifications may explore online rn-bsn programs without clinicals. These are designed for working nurses seeking to complete a BSN degree online, with minimal on-campus requirements.

If you're pursuing advanced practice roles, look into accelerated dnp programs online. These programs help qualified nurses earn a Doctor of Nursing Practice quickly, sometimes in as little as one year.

For those seeking a less intensive path, reviews and recommendations on the easiest dnp program reddit can help identify streamlined DNP options that balance rigor with flexibility.

Best Scientists Citing Raoul Herbrecht

Trending Scientists

Recently Published Articles